Allscripts Healthcare Solutions Stock Price, News & Analysis (NASDAQ:MDRX)

$13.55 -0.02 (-0.15 %)
(As of 02/22/2018 04:00 PM ET)
Previous Close$13.57
Today's Range$13.46 - $13.83
52-Week Range$11.25 - $16.13
Volume2.60 million shs
Average Volume2.01 million shs
Market Capitalization$2.39 billion
P/E Ratio-12.43
Dividend YieldN/A
Beta1.18

About Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions logoAllscripts Healthcare Solutions, Inc. (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions. The Population Health segment includes the sale of health management and coordinated care solutions, which focus on hospitals, health systems, other care facilities and accountable care organizations (ACOs). The Netsmart segment provides software and technology solutions to the health and human services industry, which includes behavioral health, addiction treatment, intellectual and developmental disability services, child and family services and public health segments, as well as to post-acute home care organizations.

Receive MDRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Software & Technology Services
Sub-IndustryHealth Care Technology
SectorMedical
SymbolNASDAQ:MDRX
CUSIP01988P10
Phone312-506-1200

Debt

Debt-to-Equity Ratio1.33%
Current Ratio0.97%
Quick Ratio0.98%

Price-To-Earnings

Trailing P/E Ratio-12.4310786139577
Forward P/E Ratio22.97
P/E Growth1.91

Sales & Book Value

Annual Sales$1.81 billion
Price / Sales1.36
Cash Flow$1.72 per share
Price / Cash7.86
Book Value$6.42 per share
Price / Book2.11

Profitability

Trailing EPS($1.09)
Net Income$-152,700,000.00
Net Margins-10.88%
Return on Equity7.36%
Return on Assets2.19%

Miscellaneous

Employees7,500
Outstanding Shares180,680,000

Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) released its earnings results on Thursday, February, 15th. The software maker reported $0.18 earnings per share for the quarter, meeting analysts' consensus estimates of $0.18. The software maker earned $547 million during the quarter, compared to the consensus estimate of $524.05 million. Allscripts Healthcare Solutions had a positive return on equity of 7.36% and a negative net margin of 10.88%. The company's revenue was up 27.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.14 EPS. View Allscripts Healthcare Solutions' Earnings History.

When will Allscripts Healthcare Solutions make its next earnings announcement?

Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Allscripts Healthcare Solutions.

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

Allscripts Healthcare Solutions updated its FY18 earnings guidance on Thursday, February, 15th. The company provided earnings per share guidance of $0.72-0.82 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.79. The company issued revenue guidance of $2.15-2.25 billion, compared to the consensus revenue estimate of $2.15 billion.

Where is Allscripts Healthcare Solutions' stock going? Where will Allscripts Healthcare Solutions' stock price be in 2018?

17 Wall Street analysts have issued 12-month price targets for Allscripts Healthcare Solutions' shares. Their forecasts range from $12.00 to $20.00. On average, they anticipate Allscripts Healthcare Solutions' share price to reach $15.97 in the next year. View Analyst Ratings for Allscripts Healthcare Solutions.

What are Wall Street analysts saying about Allscripts Healthcare Solutions stock?

Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock:

  • 1. Cantor Fitzgerald analysts commented, "Last week, an article on FierceHealthcare.com suggested that an ongoing DOJ investigation had affected the purchase price paid by Allscripts for Practice Fusion." (1/28/2018)
  • 2. According to Zacks Investment Research, "Allscripts has had a favorable run on the bourses over the last year, trading above the broader industry. The company’s solid growth in U.S. Core Solutions and Services holds promise at the moment. Allscripts Sunrise electronic health record (EHR) platform and Revenue Cycle Management Services are likely to drive the company’s top line in the quarters to come. Also, Allscripts has a leading market share in inpatient and ambulatory settings. Allscripts announced a definitive agreement to buy Practice Fusion for $100 million in cash. However, the company’s continued reliance on mergers and acquisition activities poses substantial integration risks. Intensifying competition is a major dampener. The company’s products have a long sales cycle which involves intensive decision-making at different managerial levels. Allscripts also expects a modest increase in operating expenses to support business growth over the long haul." (1/25/2018)
  • 3. Maxim Group analysts commented, "MDRX announced the acquisition of Practice Fusion, a provider of cloud- based electronic health record (EHR) platforms, for $100M in cash. The acquisition is expected to close in 1Q18. We believe Practice Fusion was sold at 1.0x-2.0x revenue, implying a $50M- $100M revenue run rate. It is expected to be marginally accretive in 2018. We estimate that the company’s recently-acquired Enterprise Information Systems (EIS) business is operating at a roughly $400M-$450M revenue run rate, significantly above our original estimate of $300M. We believe attrition in the EIS business may be lower than originally projected." (1/9/2018)

Who are some of Allscripts Healthcare Solutions' key competitors?

Who are Allscripts Healthcare Solutions' key executives?

Allscripts Healthcare Solutions' management team includes the folowing people:

  • Michael A. Klayko, Independent Chairman of the Board (Age 62)
  • Richard J. Poulton, President (Age 51)
  • Paul M. Black, Chief Executive Officer, Director (Age 59)
  • Dennis M. Olis, Chief Financial Officer, Principal Accounting Office (Age 54)
  • James R. Hewitt, Executive Vice President, Solutions Development (Age 50)
  • Lisa Khorey, Executive Vice President, Chief Client Delivery Officer (Age 50)
  • Brian P. Farley, Senior Vice President, General Counsel and Corporate Secretary; (Age 47)
  • Mara Glickman Aspinall, Independent Director (Age 54)
  • P Gregory Garrison, Independent Director (Age 63)
  • Jonathan J. Judge, Independent Director (Age 63)

Who owns Allscripts Healthcare Solutions stock?

Allscripts Healthcare Solutions' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Iridian Asset Management LLC CT (5.22%), Fuller & Thaler Asset Management Inc. (2.81%), TimesSquare Capital Management LLC (1.81%), Dalton Greiner Hartman Maher & Co. (1.66%), Glenhill Advisors LLC (1.36%) and Fisher Asset Management LLC (1.32%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, James Hewitt, Paul Black and Richard J Poulton. View Institutional Ownership Trends for Allscripts Healthcare Solutions.

Who sold Allscripts Healthcare Solutions stock? Who is selling Allscripts Healthcare Solutions stock?

Allscripts Healthcare Solutions' stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Iridian Asset Management LLC CT, Glenhill Advisors LLC, Bank of Montreal Can, Two Sigma Advisers LP, Victory Capital Management Inc., Cortina Asset Management LLC and Schwab Charles Investment Management Inc.. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley, James Hewitt, Paul Black and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions.

Who bought Allscripts Healthcare Solutions stock? Who is buying Allscripts Healthcare Solutions stock?

Allscripts Healthcare Solutions' stock was purchased by a variety of institutional investors in the last quarter, including Redmile Group LLC, Community Trust & Investment Co., Amundi Pioneer Asset Management Inc., Dalton Greiner Hartman Maher & Co., AXA, Geode Capital Management LLC, Systematic Financial Management LP and Monarch Partners Asset Management LLC. View Insider Buying and Selling for Allscripts Healthcare Solutions.

How do I buy Allscripts Healthcare Solutions stock?

Shares of Allscripts Healthcare Solutions can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Allscripts Healthcare Solutions' stock price today?

One share of Allscripts Healthcare Solutions stock can currently be purchased for approximately $13.55.

How big of a company is Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions has a market capitalization of $2.39 billion and generates $1.81 billion in revenue each year. The software maker earns $-152,700,000.00 in net income (profit) each year or ($1.09) on an earnings per share basis. Allscripts Healthcare Solutions employs 7,500 workers across the globe.

How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 312-506-1200 or via email at [email protected]


MarketBeat Community Rating for Allscripts Healthcare Solutions (MDRX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  461 (Vote Outperform)
Underperform Votes:  463 (Vote Underperform)
Total Votes:  924
MarketBeat's community ratings are surveys of what our community members think about Allscripts Healthcare Solutions and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Allscripts Healthcare Solutions (NASDAQ:MDRX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.592.562.532.47
Ratings Breakdown: 1 Sell Rating(s)
5 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $15.97$15.77$15.13$14.47
Price Target Upside: 15.46% upside3.05% upside16.89% upside11.80% upside

Allscripts Healthcare Solutions (NASDAQ:MDRX) Consensus Price Target History

Price Target History for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions (NASDAQ:MDRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/17/2018Wells Fargo & CoSet Price TargetBuy$19.00HighView Rating Details
1/28/2018Cantor FitzgeraldReiterated RatingBuy$17.00LowView Rating Details
1/18/2018Evercore ISIInitiated CoverageOutperform -> Outperform$17.50MediumView Rating Details
1/16/2018SunTrust BanksDowngradeBuy -> HoldHighView Rating Details
1/11/2018Royal Bank of CanadaSet Price TargetBuy$19.00HighView Rating Details
1/9/2018Maxim GroupReiterated RatingBuy$20.00MediumView Rating Details
1/4/2018CitigroupInitiated CoverageBuyLowView Rating Details
11/3/2017Robert W. BairdBoost Price TargetOutperform$16.00 -> $17.00N/AView Rating Details
10/27/2017KeyCorpReiterated RatingHoldN/AView Rating Details
10/3/2017Dougherty & CoReiterated RatingBuy$15.00 -> $16.00LowView Rating Details
9/11/2017CowenUpgradeMarket Perform -> Outperform$13.00 -> $16.00HighView Rating Details
8/25/2017Jefferies GroupSet Price TargetBuy$17.00LowView Rating Details
8/7/2017Morgan StanleyBoost Price TargetUnderweight$11.00 -> $12.00LowView Rating Details
7/21/2017Piper Jaffray CompaniesReiterated RatingHold$14.00LowView Rating Details
6/19/2017Leerink SwannDowngradeOutperform -> Market Perform$15.00 -> $13.00MediumView Rating Details
5/15/2017Bank of AmericaInitiated CoverageNeutral$14.00HighView Rating Details
3/24/2017Deutsche BankUpgradeHold -> Buy$12.50 -> $14.00LowView Rating Details
2/17/2017OppenheimerReiterated RatingHoldN/AView Rating Details
1/8/2017FBR & CoReiterated RatingHold$12.00N/AView Rating Details
1/3/2017Canaccord GenuityReiterated RatingBuy$17.00N/AView Rating Details
10/30/2016JPMorgan Chase & Co.Initiated CoverageBuy$15.00N/AView Rating Details
10/23/2016ArgusReiterated RatingBuy$19.00N/AView Rating Details
8/5/2016Goldman Sachs GroupBoost Price TargetNeutral$14.00 -> $16.00N/AView Rating Details
(Data available from 2/22/2016 forward)

Earnings

Allscripts Healthcare Solutions (NASDAQ:MDRX) Earnings History and Estimates Chart

Earnings by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions (NASDAQ MDRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018$0.17N/AView Earnings Details
2/15/2018Q4 2017$0.18$0.18$524.05 million$547.00 millionViewListenView Earnings Details
11/2/2017Q3 2017$0.12$0.12$429.94 million$451.20 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.15$0.11$424.94 million$426.10 millionViewListenView Earnings Details
5/4/2017Q1 2017$0.09$0.10$415.20 million$415.00 millionViewListenView Earnings Details
2/16/2017Q4 2016$0.15$0.14$424.11 million$425.40 millionViewListenView Earnings Details
11/3/2016Q3$0.15$0.14$414.92 million$392.40 millionViewListenView Earnings Details
8/4/2016Q2$0.14$0.14$403.13 million$386.50 millionViewListenView Earnings Details
5/5/2016Q1$0.12$0.13$348.51 million$346.00 millionViewListenView Earnings Details
2/18/2016Q4$0.13$0.13$357.91 million$345.60 millionViewListenView Earnings Details
11/5/2015Q315$0.12$0.13$354.67 million$355.00 millionViewListenView Earnings Details
8/4/2015Q215$0.11$0.12$347.13 million$351.70 millionViewListenView Earnings Details
5/7/2015Q115$0.09$0.08$344.73 million$335.00 millionViewListenView Earnings Details
2/26/2015Q414$0.09$0.09$358.10 million$343.00 millionViewListenView Earnings Details
11/6/2014Q314$0.10$0.06$353.00 million$348.00 millionViewListenView Earnings Details
8/7/2014Q214$0.09$0.09$353.12 million$351.30 millionViewListenView Earnings Details
5/8/2014Q114$0.07$0.07$347.98 billion$340.30 billionViewListenView Earnings Details
2/20/2014Q413$0.08$0.08$343.47 million$351.00 millionViewListenView Earnings Details
11/7/2013Q313$0.08$0.05$355.30 million$334.00 millionViewListenView Earnings Details
8/8/2013Q2 2013$0.11$0.09$360.00 million$344.80 millionViewListenView Earnings Details
5/9/2013Q1 2013$0.14$0.09$368.11 million$347.10 millionViewListenView Earnings Details
2/19/2013Q4 2012$0.21$0.16$367.07 million$367.70 millionViewListenView Earnings Details
11/8/2012Q312$0.22$0.23$376.97 million$361.00 millionViewN/AView Earnings Details
8/8/2012$0.18$0.16ViewN/AView Earnings Details
4/26/2012$0.24$0.12ViewN/AView Earnings Details
2/16/2012$0.25$0.25ViewN/AView Earnings Details
11/3/2011$0.22$0.25ViewN/AView Earnings Details
8/2/2011$0.21$0.22ViewN/AView Earnings Details
5/5/2011$0.20$0.21ViewN/AView Earnings Details
2/15/2011$0.18$0.20ViewN/AView Earnings Details
11/8/2010Q3 2010$0.16$0.17ViewN/AView Earnings Details
7/20/2010Q2 2010$0.15$0.15ViewN/AView Earnings Details
4/7/2010Q1 2010$0.14$0.14ViewN/AView Earnings Details
1/10/2010Q4 2009$0.13$0.14ViewN/AView Earnings Details
9/29/2009Q3 2009$0.13$0.14ViewN/AView Earnings Details
7/20/2009Q2 2009$0.14$0.15ViewN/AView Earnings Details
4/2/2009Q1 2009$0.12$0.14ViewN/AView Earnings Details
1/8/2009Q4 2008$0.12$0.14ViewN/AView Earnings Details
10/23/2008Q3 2008$0.13$0.13ViewN/AView Earnings Details
8/5/2008Q2 2008$0.09$0.11ViewN/AView Earnings Details
4/30/2008Q1 2008$0.10$0.07ViewN/AView Earnings Details
2/13/2008Q4 2007$0.12$0.14ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Allscripts Healthcare Solutions (NASDAQ:MDRX) Earnings Estimates

2018 EPS Consensus Estimate: $0.56
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.11$0.13$0.12
Q2 20181$0.13$0.13$0.13
Q3 20181$0.15$0.15$0.15
Q4 20181$0.16$0.16$0.16
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Allscripts Healthcare Solutions (NASDAQ:MDRX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Allscripts Healthcare Solutions (NASDAQ MDRX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.75%
Insider Trades by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions (NASDAQ MDRX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2017Richard J PoultonPresidentSell15,000$14.26$213,900.001,351,773View SEC Filing  
12/14/2017Brian FarleyEVPSell5,000$14.35$71,750.00191,607View SEC Filing  
12/1/2017James HewittSVPSell36,796$14.11$519,191.56181,766View SEC Filing  
9/15/2017Richard J. PoultonPresidentSell15,000$13.56$203,400.00View SEC Filing  
9/14/2017Brian FarleyEVPSell5,000$13.52$67,600.00196,607View SEC Filing  
9/14/2017Paul BlackCEOSell15,000$13.52$202,800.00View SEC Filing  
5/16/2017Richard J PoultonPresidentSell25,000$12.06$301,500.00412,488View SEC Filing  
3/23/2017Brian FarleySVPSell15,000$11.63$174,450.00217,861View SEC Filing  
9/15/2016James HewittSVPSell17,500$13.00$227,500.00158,104View SEC Filing  
9/15/2016Paul BlackCEOSell15,000$13.00$195,000.001,177,009View SEC Filing  
7/11/2016Dennis OlisSVPSell7,000$14.00$98,000.00210,887View SEC Filing  
7/1/2016James HewittSVPSell17,500$13.00$227,500.00175,604View SEC Filing  
6/13/2016Paul BlackCEOSell15,000$13.04$195,600.001,197,329View SEC Filing  
6/13/2016Richard J PoultonPresidentSell10,000$13.03$130,300.00343,813View SEC Filing  
4/7/2016Dennis OlisSVPSell25,000$14.00$350,000.00217,887View SEC Filing  
3/30/2016James HewittSVPSell17,500$13.31$232,925.00228,104View SEC Filing  
3/30/2016Paul BlackCEOSell15,000$13.31$199,650.001,224,939View SEC Filing  
3/14/2016Richard J PoultonPresidentSell5,000$12.85$64,250.00359,064View SEC Filing  
8/17/2015James HewittSVPSell70,000$14.17$991,900.00View SEC Filing  
12/12/2014Paul BlackCEOBuy6,500$11.51$74,815.00View SEC Filing  
11/18/2014Anita PramodaDirectorBuy2,017$12.25$24,708.25View SEC Filing  
11/13/2014Dennis ChookaszianDirectorBuy10,000$12.43$124,300.00View SEC Filing  
11/11/2014Dennis OlisSVPBuy4,400$11.26$49,544.00View SEC Filing  
11/11/2014Paul BlackCEOBuy22,180$11.26$249,746.80View SEC Filing  
11/11/2014Richard J PoultonCFOBuy4,500$11.26$50,670.00View SEC Filing  
11/11/2014Stuart L BascombDirectorBuy6,743$11.26$75,926.18View SEC Filing  
8/18/2014Michael KlaykoDirectorBuy3,500$14.41$50,435.00View SEC Filing  
3/13/2014Deborah SnowSVPSell14,740$18.75$276,375.0032,560View SEC Filing  
11/21/2013Deborah SnowSVPSell2,400$14.70$35,280.0033,655View SEC Filing  
9/9/2013Clifford B MeltzerEVPSell35,000$14.56$509,600.00View SEC Filing  
8/15/2013Michael KlaykoDirectorBuy10,000$14.80$148,000.0024,225View SEC Filing  
5/30/2013Deborah SnowSVPSell1,495$13.71$20,496.45View SEC Filing  
5/20/2013Stuart L BascombDirectorBuy3,701$14.02$51,888.02View SEC Filing  
5/15/2013Paul BlackCEOBuy7,120$14.02$99,822.40View SEC Filing  
5/14/2013Steve ShuteVPSell14,612$14.10$206,029.20View SEC Filing  
3/12/2013Paul BlackCEOBuy23,625$12.69$299,801.25View SEC Filing  
3/12/2013Stuart L BascombDirectorBuy10,000$12.64$126,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Allscripts Healthcare Solutions (NASDAQ MDRX) News Headlines

Source:
DateHeadline
Allscripts Healthcare Solutions Inc (MDRX) Receives Consensus Rating of "Buy" from BrokeragesAllscripts Healthcare Solutions Inc (MDRX) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - February 21 at 7:30 PM
Practice Fusion is scrapping free software model after agreeing to sell to AllscriptsPractice Fusion is scrapping free software model after agreeing to sell to Allscripts
finance.yahoo.com - February 21 at 5:20 PM
Allscripts to present at 2018 RBC Capital Markets Global Healthcare ConferenceAllscripts to present at 2018 RBC Capital Markets Global Healthcare Conference
finance.yahoo.com - February 21 at 8:33 AM
Allscripts Healthcare Solutions Inc Forecasted to Post Q1 2018 Earnings of $0.11 Per Share (MDRX)Allscripts Healthcare Solutions Inc Forecasted to Post Q1 2018 Earnings of $0.11 Per Share (MDRX)
www.americanbankingnews.com - February 19 at 2:04 AM
Allscripts Healthcare Solutions (MDRX) Given a $19.00 Price Target by Wells Fargo & Co AnalystsAllscripts Healthcare Solutions (MDRX) Given a $19.00 Price Target by Wells Fargo & Co Analysts
www.americanbankingnews.com - February 18 at 2:18 PM
Allscripts Healthcare Solutions (MDRX) Lifted to "Buy" at BidaskClubAllscripts Healthcare Solutions (MDRX) Lifted to "Buy" at BidaskClub
www.americanbankingnews.com - February 17 at 2:10 PM
Allscripts Healthcare Solutions (MDRX) Raised to B- at TheStreetAllscripts Healthcare Solutions (MDRX) Raised to B- at TheStreet
www.americanbankingnews.com - February 16 at 11:34 PM
Allscripts Healthcare Solutions (MDRX) Announces Quarterly  Earnings ResultsAllscripts Healthcare Solutions (MDRX) Announces Quarterly Earnings Results
www.americanbankingnews.com - February 16 at 11:40 AM
Allscripts (MDRX) to sell OneContent business to HylandAllscripts (MDRX) to sell OneContent business to Hyland
www.streetinsider.com - February 16 at 8:28 AM
Allscripts (MDRX) Q4 Earnings Meet, Revenues Beat EstimatesAllscripts (MDRX) Q4 Earnings Meet, Revenues Beat Estimates
www.zacks.com - February 16 at 8:28 AM
Allscripts fourth-quarter bookings fall short of Street estimatesAllscripts fourth-quarter bookings fall short of Street estimates
www.marketwatch.com - February 16 at 8:28 AM
Allscripts Healthcare Solutions (MDRX) Updates FY18 Earnings GuidanceAllscripts Healthcare Solutions (MDRX) Updates FY18 Earnings Guidance
www.americanbankingnews.com - February 15 at 6:02 PM
Allscripts Healthcare Solutions EPS in-line, beats on revenueAllscripts Healthcare Solutions EPS in-line, beats on revenue
seekingalpha.com - February 15 at 5:13 PM
Allscripts Healthcares Earnings OutlookAllscripts Healthcare's Earnings Outlook
finance.yahoo.com - February 15 at 5:13 PM
Allscripts to sell OneContent business to HylandAllscripts to sell OneContent business to Hyland
finance.yahoo.com - February 15 at 5:13 PM
Allscripts announces fourth quarter and 2017 full-year resultsAllscripts announces fourth quarter and 2017 full-year results
finance.yahoo.com - February 15 at 5:13 PM
AllScripts meets 4Q profit forecastsAllScripts meets 4Q profit forecasts
finance.yahoo.com - February 15 at 5:13 PM
Have Investors Already Priced In Allscripts Healthcare Solutions Inc’s (NASDAQ:MDRX) Growth?Have Investors Already Priced In Allscripts Healthcare Solutions Inc’s (NASDAQ:MDRX) Growth?
finance.yahoo.com - February 13 at 9:53 AM
Quotidian Technical Highlights on Selected Application Software Stocks -- 2U, Adobe Systems, Alarm.Com, and Allscripts Healthcare SolutionsQuotidian Technical Highlights on Selected Application Software Stocks -- 2U, Adobe Systems, Alarm.Com, and Allscripts Healthcare Solutions
www.prnewswire.com - February 13 at 7:05 AM
$523.39 Million in Sales Expected for Allscripts Healthcare Solutions Inc (MDRX) This Quarter$523.39 Million in Sales Expected for Allscripts Healthcare Solutions Inc (MDRX) This Quarter
www.americanbankingnews.com - February 10 at 6:54 AM
Allscripts Healthcare Solutions (MDRX) Set to Announce Quarterly Earnings on WednesdayAllscripts Healthcare Solutions (MDRX) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - February 7 at 1:56 AM
Allscripts Names Dennis Olis Chief Financial OfficerAllscripts Names Dennis Olis Chief Financial Officer
finance.yahoo.com - February 1 at 9:53 AM
Allscripts Healthcare Solutions Inc Expected to Earn FY2018 Earnings of $0.72 Per Share (MDRX)Allscripts Healthcare Solutions Inc Expected to Earn FY2018 Earnings of $0.72 Per Share (MDRX)
www.americanbankingnews.com - January 30 at 10:56 AM
Allscripts Healthcare Solutions (MDRX) Buy Rating Reaffirmed at Cantor FitzgeraldAllscripts Healthcare Solutions' (MDRX) Buy Rating Reaffirmed at Cantor Fitzgerald
www.americanbankingnews.com - January 28 at 8:12 PM
Allscripts Healthcare Solutions Inc (MDRX) Given Average Rating of "Buy" by AnalystsAllscripts Healthcare Solutions Inc (MDRX) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - January 27 at 7:28 PM
Allscripts Healthcare Solutions (MDRX) Upgraded to "Hold" by Zacks Investment ResearchAllscripts Healthcare Solutions (MDRX) Upgraded to "Hold" by Zacks Investment Research
www.americanbankingnews.com - January 25 at 11:48 PM
Equities Analysts Set Expectations for Allscripts Healthcare Solutions Incs FY2018 Earnings (MDRX)Equities Analysts Set Expectations for Allscripts Healthcare Solutions Inc's FY2018 Earnings (MDRX)
www.americanbankingnews.com - January 25 at 12:26 PM
Doctors, Patient Care Crippled By Allscripts Ransomware Attack: I Think Its Eroded Some TrustDoctors, Patient Care Crippled By Allscripts' Ransomware Attack: 'I Think It's Eroded Some Trust'
www.benzinga.com - January 24 at 4:00 PM
The Market In 5 Minutes: Border Wall, Allscripts Cyber Attack, Teslas New Pay PlanThe Market In 5 Minutes: Border Wall, Allscripts Cyber Attack, Tesla's New Pay Plan
finance.yahoo.com - January 24 at 4:00 PM
ICYMI: Ransomware Hits Allscripts, Trumps Tariffs, New IPOs ... - BenzingaICYMI: Ransomware Hits Allscripts, Trump's Tariffs, New IPOs ... - Benzinga
www.benzinga.com - January 24 at 8:15 AM
 Brokerages Anticipate Allscripts Healthcare Solutions Inc (MDRX) Will Announce Earnings of $0.18 Per Share Brokerages Anticipate Allscripts Healthcare Solutions Inc (MDRX) Will Announce Earnings of $0.18 Per Share
www.americanbankingnews.com - January 22 at 9:24 AM
Allscripts Healthcare Solutions (MDRX) Rating Lowered to Hold at BidaskClubAllscripts Healthcare Solutions (MDRX) Rating Lowered to Hold at BidaskClub
www.americanbankingnews.com - January 21 at 2:56 PM
Allscripts Healthcare Solutions (MDRX) Receives New Coverage from Analysts at Evercore ISIAllscripts Healthcare Solutions (MDRX) Receives New Coverage from Analysts at Evercore ISI
www.americanbankingnews.com - January 18 at 5:28 PM
Allscripts Healthcare Solutions Inc (MDRX) Short Interest UpdateAllscripts Healthcare Solutions Inc (MDRX) Short Interest Update
www.americanbankingnews.com - January 13 at 3:15 AM
Allscripts Healthcare Solutions Shows Rising Price Performance With Jump To 84 RS RatingAllscripts Healthcare Solutions Shows Rising Price Performance With Jump To 84 RS Rating
finance.yahoo.com - January 12 at 5:01 PM
Allscripts Healthcare Solutions (MDRX) Stock Rating Lowered by Zacks Investment ResearchAllscripts Healthcare Solutions (MDRX) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - January 12 at 2:50 PM
Allscripts Healthcare Solutions (MDRX) PT Raised to $19.00Allscripts Healthcare Solutions (MDRX) PT Raised to $19.00
www.americanbankingnews.com - January 11 at 11:22 AM
Maxim Group Reaffirms Buy Rating for Allscripts Healthcare Solutions (MDRX)Maxim Group Reaffirms Buy Rating for Allscripts Healthcare Solutions (MDRX)
www.americanbankingnews.com - January 9 at 8:22 AM
Health Care Sector Update for 01/08/2018: MDRX,NTEC,NVS,CELG - NasdaqHealth Care Sector Update for 01/08/2018: MDRX,NTEC,NVS,CELG - Nasdaq
www.nasdaq.com - January 8 at 5:18 PM
Allscripts To Acquire Practice Fusion For $100 Mln In Cash - Quick Facts - NasdaqAllscripts To Acquire Practice Fusion For $100 Mln In Cash - Quick Facts - Nasdaq
www.nasdaq.com - January 8 at 5:18 PM
Allscripts Healthcare Solutions (MDRX) Stock Rating Reaffirmed by Cantor FitzgeraldAllscripts Healthcare Solutions (MDRX) Stock Rating Reaffirmed by Cantor Fitzgerald
www.americanbankingnews.com - January 8 at 9:44 AM
Allscripts to acquire Practice Fusion businessAllscripts to acquire Practice Fusion business
finance.yahoo.com - January 8 at 9:42 AM
 Analysts Expect Allscripts Healthcare Solutions Inc (MDRX) Will Post Quarterly Sales of $523.38 Million Analysts Expect Allscripts Healthcare Solutions Inc (MDRX) Will Post Quarterly Sales of $523.38 Million
www.americanbankingnews.com - January 7 at 11:40 AM
Zacks: Analysts Expect Allscripts Healthcare Solutions Inc (MDRX) Will Post Earnings of $0.18 Per ShareZacks: Analysts Expect Allscripts Healthcare Solutions Inc (MDRX) Will Post Earnings of $0.18 Per Share
www.americanbankingnews.com - January 5 at 9:34 AM
Allscripts Healthcare Solutions Sees Unusually Large Options Volume (MDRX)Allscripts Healthcare Solutions Sees Unusually Large Options Volume (MDRX)
www.americanbankingnews.com - January 5 at 2:10 AM
Allscripts to release fourth-quarter and full-year 2017 financial results February 15Allscripts to release fourth-quarter and full-year 2017 financial results February 15
finance.yahoo.com - January 4 at 9:37 AM
Allscripts Healthcare Solutions (MDRX) Earns Buy Rating from Analysts at CitigroupAllscripts Healthcare Solutions (MDRX) Earns Buy Rating from Analysts at Citigroup
www.americanbankingnews.com - January 4 at 7:44 AM
Stock Traders Buy High Volume of Allscripts Healthcare Solutions Call Options (MDRX)Stock Traders Buy High Volume of Allscripts Healthcare Solutions Call Options (MDRX)
www.americanbankingnews.com - January 1 at 2:28 AM
Financial Survey: Cotiviti (COTV) versus Allscripts Healthcare Solutions (MDRX)Financial Survey: Cotiviti (COTV) versus Allscripts Healthcare Solutions (MDRX)
www.americanbankingnews.com - December 30 at 5:20 AM
Allscripts Healthcare Solutions (MDRX) Upgraded to Buy at BidaskClubAllscripts Healthcare Solutions (MDRX) Upgraded to Buy at BidaskClub
www.americanbankingnews.com - December 24 at 8:05 AM

SEC Filings

Allscripts Healthcare Solutions (NASDAQ:MDRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Allscripts Healthcare Solutions (NASDAQ:MDRX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Allscripts Healthcare Solutions (NASDAQ MDRX) Stock Chart for Thursday, February, 22, 2018

Loading chart…

This page was last updated on 2/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.